BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3108902)

  • 1. Implications of IL-2 in normal and disturbed immune functions in the chicken.
    Schauenstein K; Krömer G; Fässler R; Wick G
    Prog Clin Biol Res; 1987; 233():69-77. PubMed ID: 3108902
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced response to Con A and production of TCGF by lymphocytes of obese strain (OS) chickens with spontaneous autoimmune thyroiditis.
    Schauenstein K; Krömer G; Sundick RS; Wick G
    J Immunol; 1985 Feb; 134(2):872-9. PubMed ID: 3917478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines and receptors--their functions, structure and cloning of code genes. Interleukin-2 and receptor].
    Tagaya Y; Yodoi J
    Nihon Rinsho; 1988 May; 46(5):1002-7. PubMed ID: 3137376
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma.
    Brezinschek HP; Gruschwitz M; Sgonc R; Moormann S; Herold M; Gershwin ME; Wick G
    J Autoimmun; 1993 Dec; 6(6):719-33. PubMed ID: 8155253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin 2 receptor dysfunction in mice undergoing a graft-vs-host reaction.
    Joseph LJ; Iwasaki T; Malek TR; Shearer GM
    J Immunol; 1985 Sep; 135(3):1846-50. PubMed ID: 3926888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro T cell hyperreactivity in Obese strain (OS) chickens is due to a defect in nonspecific suppressor mechanism(s).
    Krömer G; Schauenstein K; Neu N; Stricker K; Wick G
    J Immunol; 1985 Oct; 135(4):2458-63. PubMed ID: 3875655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody?
    Osawa H; Diamantstein T
    Immunology; 1983 Mar; 48(3):617-21. PubMed ID: 6600707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of interleukin 2 receptor sites on activated T cells.
    Röllinghoff M; Scheurich P; Hardt C; Pfizenmaier K
    Behring Inst Mitt; 1983 May; (72):67-72. PubMed ID: 6242341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R; Crow MK; Russo C; Weksler ME
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
    Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Bouguet J; Fradelizi D; Reyes F
    J Immunol; 1985 Sep; 135(3):1813-8. PubMed ID: 3926884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signals required for activation and growth of autoimmune T lymphocytes.
    Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD
    J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some interleukin-3 dependent mast-cell lines also respond to interleukin-2.
    Warren HS; Hargreaves J; Hapel AJ
    Lymphokine Res; 1985; 4(3):195-204. PubMed ID: 3928979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human interleukin 2].
    Chouaib S; Fradelizi D
    Ann Immunol (Paris); 1983; 134D(2):157-65. PubMed ID: 6419669
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R
    J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.